Plasma from 36 healthy subjects, 61 patients with benign prostatic hyperplasia (BPH), 102 patients with limited prostate cancer and 65 patients with early metastatic PCa (MPCA) were examined, and hypermethylated DOCK2 was detected in the plasma of MPCA patients. The gene discussed is DOCK2; the disease is benign prostatic hyperplasia.